Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children
about
Basophil activation test: food challenge in a test tube or specialist research tool?A practical view of immunotherapy for food allergyDelayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactoseFood allergy diagnosis and therapy: where are we now?Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.Suppression of the immunologic response to peanut during immunotherapy is often transient.Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects.Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy.Data-driven programmatic approach to analysis of basophil activation tests.Diagnosis, management, and investigational therapies for food allergies.The expression of CD123 can decrease with basophil activation: implications for the gating strategy of the basophil activation testSustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.Food allergy: management, diagnosis and treatment strategies.Developments in the field of allergy in 2012 through the eyes of Clinical & Experimental Allergy.Immunotherapy in allergy and cellular tests: state of art.Oral immunotherapy for food allergy: mechanisms and role in management.Current opinion and review on peanut oral immunotherapyAn Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration.The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.Pharmacologic options for the treatment and management of food allergy.Immunotherapy for cow's milk allergy.Road map for the clinical application of the basophil activation test in food allergy.Current and Emerging Therapies for IgE-Mediated Food Allergy.Markers of tolerance development to food allergens.Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness.Future Therapies for IgE-Mediated Food AllergyHuman Immune Monitoring Techniques during Food Allergen Immunotherapy.Systematic characterization of basophil anergy.A new framework for the interpretation of IgE sensitization tests.Desensitization for Peanut Allergies in Children.The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models.The role of basophils as innate immune regulatory cells in allergy and immunotherapy.Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis.Immunotherapy for IgE-mediated wheat allergy.New treatment directions in food allergy.Basophil Activation Test in IgE-Mediated Food Allergy: Should We Follow the Flow?
P2860
Q26765130-ED266445-7798-4F92-B908-8DFEB4F2049DQ26767047-D611C4BB-1466-4D59-B0DC-CAD07771AF2EQ30384427-55EE231C-2C1B-409C-A893-862CBF3AD2A3Q34000536-CB46B6F0-D3BD-4D10-A675-41829FF273C4Q34664144-9462EE65-835E-462B-880A-A00CE0C09CFBQ35589449-5629B6C9-946C-4FFF-AB0A-A2AA7EDF27A7Q35828399-1FC0E967-6CFF-4C9D-8E8D-2611A29DFEE3Q35939076-8377985C-C507-44BA-AFA6-F88704F57675Q36406527-BBE58DDD-74C2-4F9E-ACD0-BA18A8CC1225Q36692411-9BA80050-E545-46FD-B711-7A3BD93A968CQ36758441-2AB52496-5FA0-49B1-BA0C-557BEB549F58Q37649825-B870B90B-27EE-4964-9371-98228895BB98Q38119552-D1EC92C8-8CD0-43BB-A0EE-7AB6F7818B40Q38151900-B0C51B0C-67D2-408A-81F8-FEBCAD5D31C8Q38203380-C27AD7DD-FFA4-472D-871E-4A47C0587DC8Q38235447-8ACF4F9D-E3A7-4A31-BB13-46D3A589A1DFQ38284711-8BB8C49D-AD4A-4CDA-8137-AC1A78E1A79DQ38542587-6EA9A3CF-2E5C-4E52-ADBF-B4A70FFC1933Q38551689-1EA42080-65B5-461F-A369-D6C17D58B6C9Q38569684-28BFEF95-265A-4161-ABA3-C14D4C5A9C00Q38639550-F9B05587-1983-4B27-84C0-2D0C398861BBQ38724206-C418882A-0020-4F2E-B7D6-329BD80DCBE6Q38760584-DFFD1EC3-B1E1-45D6-A0D9-BC0F69B089E3Q38861295-9A509FCB-AEC5-4536-9F3D-BA9FD514BEAFQ38890046-A40D2A58-A3F6-4550-BE18-BBB6F8FE1CB5Q39183051-335AD3B8-F8A3-4160-9EFC-CED6543A76A3Q39210376-23C7E02E-063B-427F-A7D3-9E3F6CA487C9Q39370413-5E8DFFFA-5A94-438E-B069-BD279030BC52Q39736596-AB32F3B4-0EC0-4850-841C-4A4F6B3BCD48Q40083497-BEDFA48D-BF9A-4AA6-8C4F-3BFFBE56743AQ42079184-E1806110-6789-4869-9FA9-CD68E31A45FEQ48093883-91F4AF56-757F-4675-8B55-AA8961846FADQ49183777-2E62BDC7-9357-450A-AFDC-A51E1CA9D359Q49189541-8FCA2AA6-A6F6-4DF1-BD03-690975E99F0EQ50140616-22977A9E-1328-4697-9003-1514AB0B4C0EQ52672340-41AE7B14-9994-49DE-8111-CEA8E3093746Q58616699-F72F7912-C412-47DF-AD97-B778D720BF9A
P2860
Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence of pathway-specific b ...... py in peanut-allergic children
@en
Evidence of pathway-specific b ...... y in peanut-allergic children.
@nl
type
label
Evidence of pathway-specific b ...... py in peanut-allergic children
@en
Evidence of pathway-specific b ...... y in peanut-allergic children.
@nl
prefLabel
Evidence of pathway-specific b ...... py in peanut-allergic children
@en
Evidence of pathway-specific b ...... y in peanut-allergic children.
@nl
P2093
P2860
P1476
Evidence of pathway-specific b ...... py in peanut-allergic children
@en
P2093
A Calatroni
A M Scurlock
A Thyagarajan
A Wesley Burks
M Kamalakannan
W G Shreffler
P2860
P304
P356
10.1111/J.1365-2222.2012.04028.X
P577
2012-08-01T00:00:00Z